Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
There are no as such competitors for Spyre Therapeutics.
Spyre Therapeutics has a consensus price target of $81.53.
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $74.92 last updated May 15, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Spyre Therapeutics.
Spyre Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Spyre Therapeutics.
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.